Modulation of transcriptional activation by ligand-dependent phosphorylation of the human oestrogen receptor A/B region - PubMed (original) (raw)
Modulation of transcriptional activation by ligand-dependent phosphorylation of the human oestrogen receptor A/B region
S Ali et al. EMBO J. 1993 Mar.
Abstract
Using a transient co-transfection system, we show that the human oestrogen receptor (hER) becomes phosphorylated in the presence of oestradiol (E2) as well as in the presence of the anti-oestrogens 4-hydroxy-tamoxifen (OHT) and ICI 164, 384 (ICI), although at lower efficiencies than with E2. There are multiple sites of phosphorylation in hER; using deletion and point mutants one of these sites has been mapped in the N-terminal A/B region at serine 118. Mutation of this serine to alanine caused, in a number of cell types, a significant reduction in transcriptional activation by hER from reporter genes containing an oestrogen response element (ERE), but did not affect the DNA binding properties or nuclear localization of hER. Thus phosphorylation of serine 118 is important for the action of the transcription activation function 1 (AF-1) located in the A/B region of the oestrogen receptor.
Similar articles
- Specific mutations in the estrogen receptor change the properties of antiestrogens to full agonists.
Mahfoudi A, Roulet E, Dauvois S, Parker MG, Wahli W. Mahfoudi A, et al. Proc Natl Acad Sci U S A. 1995 May 9;92(10):4206-10. doi: 10.1073/pnas.92.10.4206. Proc Natl Acad Sci U S A. 1995. PMID: 7753783 Free PMC article. - Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens.
Montano MM, Ekena K, Krueger KD, Keller AL, Katzenellenbogen BS. Montano MM, et al. Mol Endocrinol. 1996 Mar;10(3):230-42. doi: 10.1210/mend.10.3.8833652. Mol Endocrinol. 1996. PMID: 8833652
Cited by
- Endocrinology and hormone therapy in breast cancer: new insight into estrogen receptor-alpha function and its implication for endocrine therapy resistance in breast cancer.
Schiff R, Osborne CK. Schiff R, et al. Breast Cancer Res. 2005;7(5):205-11. doi: 10.1186/bcr1287. Epub 2005 Jul 20. Breast Cancer Res. 2005. PMID: 16168139 Free PMC article. - The role of calcium in the activation of estrogen receptor-alpha.
Divekar SD, Storchan GB, Sperle K, Veselik DJ, Johnson E, Dakshanamurthy S, Lajiminmuhip YN, Nakles RE, Huang L, Martin MB. Divekar SD, et al. Cancer Res. 2011 Mar 1;71(5):1658-68. doi: 10.1158/0008-5472.CAN-10-1899. Epub 2011 Jan 6. Cancer Res. 2011. PMID: 21212417 Free PMC article. - Anastrozole Regulates Fatty Acid Synthase in Breast Cancer.
Cairns J, Ingle JN, Kalari KR, Goetz MP, Weinshilboum RM, Gao H, Li H, Bari MG, Wang L. Cairns J, et al. Mol Cancer Ther. 2022 Jan;21(1):206-216. doi: 10.1158/1535-7163.MCT-21-0509. Epub 2021 Oct 19. Mol Cancer Ther. 2022. PMID: 34667110 Free PMC article. - The search for ESR1 mutations in breast cancer.
Oesterreich S, Davidson NE. Oesterreich S, et al. Nat Genet. 2013 Dec;45(12):1415-6. doi: 10.1038/ng.2831. Nat Genet. 2013. PMID: 24270445 Free PMC article. - Integrative genome-wide expression analysis bears evidence of estrogen receptor-independent transcription in heregulin-stimulated MCF-7 cells.
Nagashima T, Suzuki T, Kondo S, Kuroki Y, Takahashi K, Ide K, Yumoto N, Hasegawa A, Toyoda T, Kojima T, Konagaya A, Suzuki H, Hayashizaki Y, Sakaki Y, Hatakeyama M. Nagashima T, et al. PLoS One. 2008 Mar 19;3(3):e1803. doi: 10.1371/journal.pone.0001803. PLoS One. 2008. PMID: 18350142 Free PMC article.
References
- Mol Endocrinol. 1987 May;1(5):355-62 - PubMed
- Cell. 1990 Sep 21;62(6):1177-87 - PubMed
- Science. 1988 May 13;240(4854):889-95 - PubMed
- Proc Natl Acad Sci U S A. 1989 Feb;86(4):1218-22 - PubMed
- Cell. 1987 Dec 24;51(6):941-51 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources